CMPX CIK: 1738021

Compass Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.7
FY22:
−34.1
FY23:
−40.6
FY24:
−44.9
FY25:
−49.1
Change from FY21 to FY25
millions USD
FY21:
−1.77
FY22:
−151
FY23:
27.0
FY24:
46.8
FY25:
−93.3
Change from FY21 to FY25
millions USD
FY21:
119
FY22:
75.8
FY23:
2.94
FY24:
17.3
FY25:
130
millions USD
FY21:
97.2
FY22:
−110
FY23:
−10.7
FY24:
19.3
FY25:
−12.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−21.2
FY22:
−34.3
FY23:
−40.6
FY24:
−44.9
FY25:
−49.2

All amounts in millions USD Data source:SEC EDGAR